405 related articles for article (PubMed ID: 37531575)
21. Surgical portosystemic shunts versus devascularisation procedures for prevention of variceal rebleeding in people with hepatosplenic schistosomiasis.
Ede CJ; Nikolova D; Brand M
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD011717. PubMed ID: 30073663
[TBL] [Abstract][Full Text] [Related]
22. Long-term clinical outcome of patients with cirrhosis and refractory ascites treated with transjugular intrahepatic portosystemic shunt insertion.
Tan HK; James PD; Sniderman KW; Wong F
J Gastroenterol Hepatol; 2015 Feb; 30(2):389-95. PubMed ID: 25168607
[TBL] [Abstract][Full Text] [Related]
23. Influence of the secondary deployment of expanded polytetrafluoroethylene-covered stent grafts on maintenance of transjugular intrahepatic portosystemic shunt patency.
Jirkovsky V; Fejfar T; Safka V; Hulek P; Krajina A; Chovanec V; Raupach J; Lojik M; Vanasek T; Renc O; Ali SM
J Vasc Interv Radiol; 2011 Jan; 22(1):55-60. PubMed ID: 21106389
[TBL] [Abstract][Full Text] [Related]
24. Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study.
Bureau C; Garcia-Pagan JC; Otal P; Pomier-Layrargues G; Chabbert V; Cortez C; Perreault P; Péron JM; Abraldes JG; Bouchard L; Bilbao JI; Bosch J; Rousseau H; Vinel JP
Gastroenterology; 2004 Feb; 126(2):469-75. PubMed ID: 14762784
[TBL] [Abstract][Full Text] [Related]
25. ePTFE-TIPS vs repetitive LVP plus albumin for the treatment of refractory ascites in patients with cirrhosis.
Bucsics T; Hoffman S; Grünberger J; Schoder M; Matzek W; Stadlmann A; Mandorfer M; Schwabl P; Ferlitsch A; Peck-Radosavljevic M; Trauner M; Karner J; Karnel F; Reiberger T
Liver Int; 2018 Jun; 38(6):1036-1044. PubMed ID: 29091351
[TBL] [Abstract][Full Text] [Related]
26. Incidence, natural history, and risk factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stent grafts.
Riggio O; Angeloni S; Salvatori FM; De Santis A; Cerini F; Farcomeni A; Attili AF; Merli M
Am J Gastroenterol; 2008 Nov; 103(11):2738-46. PubMed ID: 18775022
[TBL] [Abstract][Full Text] [Related]
27. Polytetrafluoroethylene-Covered Stent Graft Versus Bare Stent in Transjugular Intrahepatic Portosystemic Shunt: Systematic Review and Meta-Analysis.
Triantafyllou T; Aggarwal P; Gupta E; Svetanoff WJ; Bhirud DP; Singhal S
J Laparoendosc Adv Surg Tech A; 2018 Jul; 28(7):867-879. PubMed ID: 29356589
[TBL] [Abstract][Full Text] [Related]
28. Clinical Efficacy of Transjugular Intrahepatic Portosystemic Shunt Created with Expanded Polytetrafluoroethylene-Covered Stent-Grafts: 8-mm Versus 10-mm.
Luo X; Wang X; Zhu Y; Xi X; Zhao Y; Yang J; Li X; Yang L
Cardiovasc Intervent Radiol; 2019 May; 42(5):737-743. PubMed ID: 30643936
[TBL] [Abstract][Full Text] [Related]
29. Covered vs. uncovered stents for transjugular intrahepatic portosystemic shunt: a randomized controlled trial.
Perarnau JM; Le Gouge A; Nicolas C; d'Alteroche L; Borentain P; Saliba F; Minello A; Anty R; Chagneau-Derrode C; Bernard PH; Abergel A; Ollivier-Hourmand I; Gournay J; Ayoub J; Gaborit C; Rusch E; Giraudeau B;
J Hepatol; 2014 May; 60(5):962-8. PubMed ID: 24480619
[TBL] [Abstract][Full Text] [Related]
30. Long-term effects and complications of the transjugular intrahepatic portosystemic shunt: a single-centre experience.
Kraglund F; Jepsen P; Amanavicius N; Aagaard NK
Scand J Gastroenterol; 2019 Jul; 54(7):899-904. PubMed ID: 31203699
[No Abstract] [Full Text] [Related]
31. Transjugular Intrahepatic Portosystemic Shunt Using the New Gore Viatorr Controlled Expansion Endoprosthesis: Prospective, Single-Center, Preliminary Experience.
Miraglia R; Maruzzelli L; Di Piazza A; Mamone G; Caruso S; Gentile G; Tuzzolino F; Floridia G; Petridis I; Volpes R; Luca A
Cardiovasc Intervent Radiol; 2019 Jan; 42(1):78-86. PubMed ID: 30073477
[TBL] [Abstract][Full Text] [Related]
32. TIPS for refractory ascites: a 6-year single-center experience with expanded polytetrafluoroethylene-covered stent-grafts.
Bercu ZL; Fischman AM; Kim E; Nowakowski FS; Patel RS; Schiano TD; Chang CY; Lookstein RA
AJR Am J Roentgenol; 2015 Mar; 204(3):654-61. PubMed ID: 25714299
[TBL] [Abstract][Full Text] [Related]
33. TIPS versus paracentesis for cirrhotic patients with refractory ascites.
Saab S; Nieto JM; Lewis SK; Runyon BA
Cochrane Database Syst Rev; 2006 Oct; 2006(4):CD004889. PubMed ID: 17054221
[TBL] [Abstract][Full Text] [Related]
34. Preliminary results of a new expanded-polytetrafluoroethylene-covered stent-graft for transjugular intrahepatic portosystemic shunt procedures.
Otal P; Smayra T; Bureau C; Peron JM; Chabbert V; Chemla P; Joffre F; Vinel JP; Rousseau H
AJR Am J Roentgenol; 2002 Jan; 178(1):141-7. PubMed ID: 11756108
[TBL] [Abstract][Full Text] [Related]
35. Treatment for hepatorenal syndrome in people with decompensated liver cirrhosis: a network meta-analysis.
Best LM; Freeman SC; Sutton AJ; Cooper NJ; Tng EL; Csenar M; Hawkins N; Pavlov CS; Davidson BR; Thorburn D; Cowlin M; Milne EJ; Tsochatzis E; Gurusamy KS
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD013103. PubMed ID: 31513287
[TBL] [Abstract][Full Text] [Related]
36. Sclerotherapy versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis.
Gattini D; Cifuentes LI; Torres-Robles R; Gana JC
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD011573. PubMed ID: 32133620
[TBL] [Abstract][Full Text] [Related]
37. Band ligation versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis.
Cifuentes LI; Gattini D; Torres-Robles R; Gana JC
Cochrane Database Syst Rev; 2021 Jan; 1(1):CD011561. PubMed ID: 33522602
[TBL] [Abstract][Full Text] [Related]
38. Prognostic Factors for Acute Transjugular Intrahepatic Portosystemic Shunt Occlusion Using Expanded Polytetrafluoroethylene-Covered Stent.
Wang X; Luo X; Zhao M; Song J; Li X; Yang L
Dig Dis Sci; 2020 Oct; 65(10):3032-3039. PubMed ID: 31853780
[TBL] [Abstract][Full Text] [Related]
39. Clinical efficacy of transjugular intrahepatic portosystemic shunt created with covered stents with different diameters: results of a randomized controlled trial.
Riggio O; Ridola L; Angeloni S; Cerini F; Pasquale C; Attili AF; Fanelli F; Merli M; Salvatori FM
J Hepatol; 2010 Aug; 53(2):267-72. PubMed ID: 20537753
[TBL] [Abstract][Full Text] [Related]
40. The presence of spontaneous portosystemic shunts increases the risk of complications after transjugular intrahepatic portosystemic shunt (TIPS) placement.
Borentain P; Soussan J; Resseguier N; Botta-Fridlund D; Dufour JC; Gérolami R; Vidal V
Diagn Interv Imaging; 2016 Jun; 97(6):643-50. PubMed ID: 26947721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
